Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. scores highest on Anchor (49) and lowest on Nitro (17). Its PosiPenta is 35.02 out of 100, weaker than most similar companies.
On the Penta Grid this week, Tvardi Therapeutics, Inc. is Grid #670 of 837 in the Healthcare sector in United States, and Grid #3,297 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. | 35.02 | 32 | 31 | 17 | 46 | 49 |
| Femasys Inc. | 20.59 | 19 | 34 | 12 | 12 | 26 |
| Daré Bioscience, Inc. | 27.26 | 0 | 53 | 18 | 19 | 46 |
| Cerenome, Inc. | 28.31 | 25 | 31 | 14 | 41 | 30 |
| Vyome Holdings, Inc. | 55.52 | 73 | 86 | 25 | 42 | 52 |
| IRIDEX Corporation | 44.62 | 17 | 75 | 47 | 27 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.36 |
| P/B ratio | 1.61 |
EEarnings
| Trailing EPS | ₹-268.99 |
| Forward EPS | ₹-211.92 |
NNitro
| Price | 95.66 |
| 52-week high | 629.85 |
| 52-week low | 88.08 |
| Fall from 52-week high | 84.8% |
TTorque
| Return on equity (ROE) | -126.19% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹127 Cr |
| Insider holding | 24.36% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Tvardi Therapeutics, Inc.'s PosiPenta score?
Tvardi Therapeutics, Inc.'s PosiPenta is 35.02 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Tvardi Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Tvardi Therapeutics, Inc. is Grid #670 of 837 in the Healthcare sector in United States, and Grid #3,297 of 4,000 in United States.
Which PosiPenta pillar is strongest for Tvardi Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Tvardi Therapeutics, Inc.?
Nitro (momentum), with a score of 17 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.